Log In
Print
BCIQ
Print
Print this Print this
 

Long-acting pegylated Factor IX

  Manage Alerts
Collapse Summary General Information
Company Pro Bono Bio Group plc
DescriptionRecombinant Factor IX proteins conjugated to a polyethylene glycol molecule using PolyTherics' TheraPEG technology
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationHemophilia
Partner

PolyTherics Ltd.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today